SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Seattle Genetics Reports TUKYSA Approval For Treatment Of Patients With Metastatic HER2-Positive Breast Cancer In Switzerland

Benzinga · 05/12/2020 12:01